Friday, February 10, 2023 Daily Archives

BMS sees CAR-T sales rocket in line with increased capacity

by

Bristol Myers Squibb will continue to expand vector and drug product capacity for Abecma and Breyanzi but says manufacturing success is just as essential in ensuring supply. For the full year 2022, Bristol Myers Squibb (BMS) reported its chimeric antigen receptor (CAR) T-cell therapies Abecma (ide-cel) and Breyanzi pulled in $388 million and $182 million, respectively – up from $164 million and $87 million the year prior. While full year comparisons are slightly unfair as both drugs received approval in…

February 10, 2023

Lonza expanding NH biologics plant

by

CDMO Lonza is adding further manufacturing and parking capabilities at its Portsmouth, New Hampshire site. Contract development manufacturing organization (CDMO) Lonza is constructing additional production and parking space on one of the unoccupied parcels at its Pease International Tradeport home in Portsmouth. A spokesperson for Lonza confirmed the expansion but told BioProcess Insider “many aspects of the project remain confidential, and we cannot comment any further on the plans beyond the publicly available information.” The Pease Development Authority board of…

February 10, 2023

Voices of Biotech: Bayer VP on driving diversity in life sciences

by

Deepa Talpade discusses how women can reach their full potential in life sciences through schemes like Bayer’s I&D Xcelerate program in the first episode of our Voices of Biotech podcast. Concurrent with International Day of Women and Girls in Science (Friday 10 February), the BioProcess Insider Expression Platform has launched Voices of Biotech – a podcast that celebrates women and minorities in science and what more can be done to amplify their voices. Despite the progress over the last decade,…

February 10, 2023